APO RESEARCH · REPORT
Hemostats
Hemostats are agents used to compress or treat bleeding vessels in order to arrest hemorrhage. These products may reduce operating room time and decrease the number of blood transfusions required in surgical procedures. Hemostatic gents are available in various forms including pads, sponges, liquids, and powders.
Product & engineering
Understand the product.
Hemostats are agents used to compress or treat bleeding vessels in order to arrest hemorrhage. These products may reduce operating room time and decrease the number of blood transfusions required in surgical procedures. Hemostatic gents are available in various forms including pads, sponges, liquids, and powders.
Selected research
Industry Research
Hemostats Industry Research Report 2026
Market perspective
Hemostats are agents used to compress or treat bleeding vessels in order to arrest hemorrhage. These products may reduce operating room time and decrease the number of blood transfusions required in surgical procedures. Hemostatic gents are available in various forms including pads, sponges, liquids, and powders.
Global Hemostats key players include Ethicon, Inc., Pfizer, Inc., Baxter International Inc., C. R. Bard, The Medicines Company, etc. Global top five manufacturers hold a share over 55%.
North America is the largest market, with a share about 35%, followed by China, and Europe, both have a share over 35 percent.
Read the full market overview
In terms of product, Thrombin-Based Hemostats is the largest segment, with a share over 40%. And in terms of application, the largest application is Hospital Treatment, followed by Prehospital Treatment, etc.
Report Scope
This report quantifies the global Hemostats market in terms of revenue (US$ million) and, where applicable, sales volume (K Pcs), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Pcs) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Hemostats Market by Company
Ethicon
Pfizer
Baxter International Inc.
C. R. Bard
The Medicines Company
Anika Therapeutics
Advanced Medical Solutions
Integra LifeSciences Corporation
B Braun Melsungen AG
Gelita Medical GmbH
Equimedical
Vascular Solutions
Marine Polymer Technologies
Z-Medica, LLC
CryoLife
BioCer Entwicklungs-GmbH.
Biom'Up SAS
Hemostats Segment by Type
Thrombin-Based Hemostats
Oxidized Regenerated Cellulose Based Hemostats
Combination Hemostats
Gelatin Based Hemostats
Collagen Based Hemostats
Hemostats Segment by Application
Prehospital Treatment
Hospital Treatment
Hemostats Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hemostats market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hemostats and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hemostats.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Hemostats manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Hemostats by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Hemostats in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Thrombin-Based Hemostats
- Oxidized Regenerated Cellulose Based Hemostats
- Combination Hemostats
- Gelatin Based Hemostats
- Collagen Based Hemostats
Applications
- Prehospital Treatment
- Hospital Treatment
Companies covered
- Ethicon
- Pfizer
- Baxter International Inc.
- C. R. Bard
- The Medicines Company
- Anika Therapeutics
- Advanced Medical Solutions
- Integra LifeSciences Corporation
- B Braun Melsungen AG
- Gelita Medical GmbH
- Equimedical
- Vascular Solutions
- Marine Polymer Technologies
- Z-Medica, LLC
- CryoLife
- BioCer Entwicklungs-GmbH.
- Biom'Up SAS
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Hemostats Market Size (2021-2032)
- 2.2.2 Global Hemostats Sales (2021-2032)
- 2.2.3 Global Hemostats Market Average Price (2021-2032)
- 2.3 Hemostats by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Thrombin-Based Hemostats
- 2.3.3 Oxidized Regenerated Cellulose Based Hemostats
- 2.3.4 Combination Hemostats
- 2.3.5 Gelatin Based Hemostats
- 2.3.6 Collagen Based Hemostats
- 2.4 Hemostats by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Prehospital Treatment
- 2.4.3 Hospital Treatment
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Hemostats Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Hemostats Sales (K Pcs) of Manufacturers (2021-2026)
- 3.3 Global Hemostats Revenue of Manufacturers (2021-2026)
- 3.4 Global Hemostats Average Price by Manufacturers (2021-2026)
- 3.5 Global Hemostats Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Hemostats, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Hemostats, Product Type & Application
- 3.8 Global Manufacturers of Hemostats, Established Date
- 3.9 Global Hemostats Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Ethicon
- 4.1.1 Ethicon Company Information
- 4.1.2 Ethicon Business Overview
- 4.1.3 Ethicon Hemostats Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Ethicon Hemostats Product Portfolio
- 4.1.5 Ethicon Recent Developments
- 4.2 Pfizer
- 4.2.1 Pfizer Company Information
- 4.2.2 Pfizer Business Overview
- 4.2.3 Pfizer Hemostats Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Pfizer Hemostats Product Portfolio
- 4.2.5 Pfizer Recent Developments
- 4.3 Baxter International Inc.
- 4.3.1 Baxter International Inc. Company Information
- 4.3.2 Baxter International Inc. Business Overview
- 4.3.3 Baxter International Inc. Hemostats Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Baxter International Inc. Hemostats Product Portfolio
- 4.3.5 Baxter International Inc. Recent Developments
- 4.4 C. R. Bard
- 4.4.1 C. R. Bard Company Information
- 4.4.2 C. R. Bard Business Overview
- 4.4.3 C. R. Bard Hemostats Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 C. R. Bard Hemostats Product Portfolio
- 4.4.5 C. R. Bard Recent Developments
- 4.5 The Medicines Company
- 4.5.1 The Medicines Company Company Information
- 4.5.2 The Medicines Company Business Overview
- 4.5.3 The Medicines Company Hemostats Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 The Medicines Company Hemostats Product Portfolio
- 4.5.5 The Medicines Company Recent Developments
- 4.6 Anika Therapeutics
- 4.6.1 Anika Therapeutics Company Information
- 4.6.2 Anika Therapeutics Business Overview
- 4.6.3 Anika Therapeutics Hemostats Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Anika Therapeutics Hemostats Product Portfolio
- 4.6.5 Anika Therapeutics Recent Developments
- 4.7 Advanced Medical Solutions
- 4.7.1 Advanced Medical Solutions Company Information
- 4.7.2 Advanced Medical Solutions Business Overview
- 4.7.3 Advanced Medical Solutions Hemostats Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Advanced Medical Solutions Hemostats Product Portfolio
- 4.7.5 Advanced Medical Solutions Recent Developments
- 4.8 Integra LifeSciences Corporation
- 4.8.1 Integra LifeSciences Corporation Company Information
- 4.8.2 Integra LifeSciences Corporation Business Overview
- 4.8.3 Integra LifeSciences Corporation Hemostats Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Integra LifeSciences Corporation Hemostats Product Portfolio
- 4.8.5 Integra LifeSciences Corporation Recent Developments
- 4.9 B Braun Melsungen AG
- 4.9.1 B Braun Melsungen AG Company Information
- 4.9.2 B Braun Melsungen AG Business Overview
- 4.9.3 B Braun Melsungen AG Hemostats Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 B Braun Melsungen AG Hemostats Product Portfolio
- 4.9.5 B Braun Melsungen AG Recent Developments
- 4.10 Gelita Medical GmbH
- 4.10.1 Gelita Medical GmbH Company Information
- 4.10.2 Gelita Medical GmbH Business Overview
- 4.10.3 Gelita Medical GmbH Hemostats Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Gelita Medical GmbH Hemostats Product Portfolio
- 4.10.5 Gelita Medical GmbH Recent Developments
- 4.11 Equimedical
- 4.11.1 Equimedical Company Information
- 4.11.2 Equimedical Business Overview
- 4.11.3 Equimedical Hemostats Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Equimedical Hemostats Product Portfolio
- 4.11.5 Equimedical Recent Developments
- 4.12 Vascular Solutions
- 4.12.1 Vascular Solutions Company Information
- 4.12.2 Vascular Solutions Business Overview
- 4.12.3 Vascular Solutions Hemostats Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Vascular Solutions Hemostats Product Portfolio
- 4.12.5 Vascular Solutions Recent Developments
- 4.13 Marine Polymer Technologies
- 4.13.1 Marine Polymer Technologies Company Information
- 4.13.2 Marine Polymer Technologies Business Overview
- 4.13.3 Marine Polymer Technologies Hemostats Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Marine Polymer Technologies Hemostats Product Portfolio
- 4.13.5 Marine Polymer Technologies Recent Developments
- 4.14 Z-Medica, LLC
- 4.14.1 Z-Medica, LLC Company Information
- 4.14.2 Z-Medica, LLC Business Overview
- 4.14.3 Z-Medica, LLC Hemostats Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Z-Medica, LLC Hemostats Product Portfolio
- 4.14.5 Z-Medica, LLC Recent Developments
- 4.15 CryoLife
- 4.15.1 CryoLife Company Information
- 4.15.2 CryoLife Business Overview
- 4.15.3 CryoLife Hemostats Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 CryoLife Hemostats Product Portfolio
- 4.15.5 CryoLife Recent Developments
- 4.16 BioCer Entwicklungs-GmbH.
- 4.16.1 BioCer Entwicklungs-GmbH. Company Information
- 4.16.2 BioCer Entwicklungs-GmbH. Business Overview
- 4.16.3 BioCer Entwicklungs-GmbH. Hemostats Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 BioCer Entwicklungs-GmbH. Hemostats Product Portfolio
- 4.16.5 BioCer Entwicklungs-GmbH. Recent Developments
- 4.17 Biom'Up SAS
- 4.17.1 Biom'Up SAS Company Information
- 4.17.2 Biom'Up SAS Business Overview
- 4.17.3 Biom'Up SAS Hemostats Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Biom'Up SAS Hemostats Product Portfolio
- 4.17.5 Biom'Up SAS Recent Developments
5 Global Hemostats Market Scenario by Region
- 5.1 Global Hemostats Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Hemostats Sales by Region: 2021-2032
- 5.2.1 Global Hemostats Sales by Region: 2021-2026
- 5.2.2 Global Hemostats Sales by Region: 2027-2032
- 5.3 Global Hemostats Revenue by Region: 2021-2032
- 5.3.1 Global Hemostats Revenue by Region: 2021-2026
- 5.3.2 Global Hemostats Revenue by Region: 2027-2032
- 5.4 North America Hemostats Market Facts & Figures by Country
- 5.4.1 North America Hemostats Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Hemostats Sales by Country (2021-2032)
- 5.4.3 North America Hemostats Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Hemostats Market Facts & Figures by Country
- 5.5.1 Europe Hemostats Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Hemostats Sales by Country (2021-2032)
- 5.5.3 Europe Hemostats Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Hemostats Market Facts & Figures by Country
- 5.6.1 Asia Pacific Hemostats Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Hemostats Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Hemostats Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Hemostats Market Facts & Figures by Country
- 5.7.1 South America Hemostats Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Hemostats Sales by Country (2021-2032)
- 5.7.3 South America Hemostats Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Hemostats Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Hemostats Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Hemostats Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Hemostats Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Hemostats Sales by Type (2021-2032)
- 6.1.1 Global Hemostats Sales by Type (2021-2032) & (K Pcs)
- 6.1.2 Global Hemostats Sales Market Share by Type (2021-2032)
- 6.2 Global Hemostats Revenue by Type (2021-2032)
- 6.2.1 Global Hemostats Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Hemostats Revenue Market Share by Type (2021-2032)
- 6.3 Global Hemostats Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Hemostats Sales by Application (2021-2032)
- 7.1.1 Global Hemostats Sales by Application (2021-2032) & (K Pcs)
- 7.1.2 Global Hemostats Sales Market Share by Application (2021-2032)
- 7.2 Global Hemostats Revenue by Application (2021-2032)
- 7.2.1 Global Hemostats Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Hemostats Revenue Market Share by Application (2021-2032)
- 7.3 Global Hemostats Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Hemostats Value Chain Analysis
- 8.1.1 Hemostats Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Hemostats Production Mode & Process
- 8.2 Hemostats Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Hemostats Distributors
- 8.2.3 Hemostats Customers
9 Global Hemostats Analyzing Market Dynamics
- 9.1 Hemostats Industry Trends
- 9.2 Hemostats Industry Drivers
- 9.3 Hemostats Industry Opportunities and Challenges
- 9.4 Hemostats Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst